Consolidated Balance Sheets - USD ($) $ in Millions	Oct. 26, 2025	Oct. 27, 2024
Current assets:
Cash and cash equivalents	$ 7,241	$ 8,022
Short-term investments	1,332	1,449
Accounts receivable, net	5,185	5,234
Inventories	5,915	5,421
Other current assets	1,208	1,094
Total current assets	20,881	21,220
Long-term investments	4,327	2,787
Property, plant and equipment, net	4,610	3,339
Goodwill	3,707	3,732
Purchased technology and other intangible assets, net	226	249
Deferred income taxes and other assets	2,548	3,082
Total assets	36,299	34,409
Current liabilities:
Short-term debt	100	799
Accounts payable and accrued expenses	5,333	4,820
Contract liabilities	2,566	2,849
Total current liabilities	7,999	8,468
Long-term debt	6,455	5,460
Income taxes payable	356	670
Other liabilities	1,074	810
Total liabilities	15,884	15,408
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock: $0.01 par value per share; 1 shares authorized; no shares issued	0	0
Common stock: $0.01 par value per share; 2,500 shares authorized; 793 and 818 shares outstanding at 2025 and 2024, respectively	8	8
Additional paid-in capital	10,333	9,660
Retained earnings	55,227	49,651
Treasury stock: 1,241 and 1,211 shares at 2025 and 2024, respectively	(45,043)	(40,150)
Accumulated other comprehensive loss	(110)	(168)
Total stockholders’ equity	20,415	19,001
Total liabilities and stockholders’ equity	$ 36,299	$ 34,409